GF
APGN

Gabelli Funds’s Apexigen, Inc. Common Stock APGN Stock Holding History

Gabelli Funds’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,229
Closed -$102K – 1465
2021
Q4 		$102K Hold
10,229
– – ﹤0.01% 1302
2021
Q3 		$102K Hold
10,229
– – ﹤0.01% 1282
2021
Q2 		$102K Buy
+10,229
New +$101K ﹤0.01% 1276

Other funds holding APGN

PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Gabelli Funds's APGN Position: Q1 2022 in Review

Gabelli Funds sold out of Apexigen, Inc. Common Stock (APGN) in Q1 2022, closing a stake of 10,229 shares — an estimated $102K sold.

Gabelli Funds first reported a position in APGN in Q2 2021 and held it in 3 quarters. The position peaked at $102K in Q4 2021. 40 funds tracked by Wall St. Rank hold APGN as of Q1 2022.

  • Gabelli Funds reported no remaining Apexigen, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Gabelli Funds sold 10,229 Apexigen, Inc. Common Stock shares in Q1 2022, an estimated $102K.
  • Gabelli Funds first reported a position in Apexigen, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Gabelli Funds's Apexigen, Inc. Common Stock position peaked at $102K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q1 2022.

Based on Gabelli Funds's 13F filing for Q1 2022, filed 13 May 2022.